Current Issue

VOL 14 NO 4 • May/Jun 2023

This issue’s cover illustration depicts highlights from JADPRO Live 2022.


Tips for Writing a Research Protocol


A brilliant advanced practitioner colleague, whose article you will find in this issue, asked whether JADPRO would publish her successfully funded grant application. When I asked about her motivation to become a researcher and seek grant funding after years of a successful clinical career, she ha...

Research and Scholarship

Research Strategy for the Development of a Quality-of-Life Decision-Making Model for Older Patients With Acute Myeloid Leukemia

Sara M. Tinsley-Vance, PhD, APRN, AOCN®

Prior to becoming a nurse and then nurse practitioner, I wanted to make an impact on the world by being a researcher. My career goals included a PhD. My desire to get married and start a family pushed that career goal down my life timeline to mid-career, after my children graduated from high scho...

Research and Scholarship

Distress in Neuro-Oncology Patients and Its Implications for Communication

Carolin Roos,(1) Johannes Weller,(1) MD, Christiane Landwehr,(1) Anja Sciermoch,(2) Cathrina Duffy,(1) MD, Karoline Kohlmann,(1) MD, Christina Schaub,(1) MD, Theophilos Tzaridis,(1) MD, Matthias Schneider,(2) MD, Patrick Schuss,(2) MD, Ulrich Herrlinger,(1) MD, and Niklas Schäfer,(1) MD

Patients with cancer experience a significant burden in their daily life resulting from a variety of symptoms, such as physical or cognitive impairment, as well as fatigue. Furthermore, psychosocial stress due to prognostic awareness, disturbed social or role functioning, and a premature end to w...

Review Article

Management of Ocular Toxicity in Patients Receiving Belantamab Mafodotin

Rebecca Lu, MSN, FNP-C, Ashley Morphey, RN, MSN, CCRP, FelIcia Diaz, MSN, APRN, FNP-BC, AOCNP®, Jessica Chen, RN, MSN, OCN®, FNP-C, Azadeh Razmandi, OD, FAAO, and Tiffany Richards, PhD, ANP-BC, AOCNP®

Multiple myeloma is a malignancy of the plasma cell characterized by the production of monoclonal immunoglobulins, bone marrow infiltration of malignant plasma cells, anemia, lytic bone lesions, hypercalcemia, and renal failure. In 2023, it is estimated that approximately 35,730 new cases of mult...

Review Article

Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’

Dallas R. Lawry, DNP, FNP-C, AOCNP®

In 1999, long-time euthanasia advocate, Dr. Jack Kevorkian, was found guilty of second-degree murder for the death of Thomas Youk, a 52-year-old man suffering through end-stage amyotrophic lateral sclerosis. Kevorkian was an American pathologist who assisted patients with their own “suicides.” Al...

Grand Rounds

Management of Patients With Advanced Gastrointestinal Stromal Tumor: Emphasis on Fourth-Line Treatment With Ripretinib

Sandra Brackert,(1) NP, and Kathleen Polson,(2) NP

Case Study A 65-year-old female who was working full time and caring for her special needs child presented to her primary care physician with long-term abdominal pain and weight loss (Figure 1). She was referred for imaging where an abdominal/pelvic CT scan revealed a 4-cm mass at the gastroesoph...

Practice Matters

Value Assessment of Oncology Pharmacist Interventions

Mallika P. Patel, PharmD, CPP, Sally Y. Barbour, PharmD, BCOP, CPP, FHOPA, and Meredith T. Moorman, PharmD, BCOP, CPP

In a 2020 study by Meleis and colleagues in the Journal of the Advanced Practitioner in Oncology, the authors report on the role and perceived impact of ambulatory oncology clinical pharmacists (AOCPs). This article seeks to further investigate this data. The AOCPs are integrated into the clinic ...

Diagnostic Snapshot

Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor

Amy Henderson, ANP-BC, AOCNP®, and Salwan Al Mutar, MD

History Mrs. R is a 47-year-old Hispanic female with no significant past medical history who initially presented in Mexico with a 6-month duration of epigastric abdominal pain, abdominal bloating, watery diarrhea, and facial flushing. She underwent a CT of the chest/abdomen/pelvis with contrast i...

Section Seperator
Section Seperator
Section Seperator
Section Seperator
Copyright © 2010-2023 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.